MiMedx Group Inc (NAS:MDXG)
$ 6.13 -0.1 (-1.61%) Market Cap: 899.94 Mil Enterprise Value: 850.15 Mil PE Ratio: 9.81 PB Ratio: 5.35 GF Score: 76/100

MiMedx Group Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript

Jun 23, 2021 / 03:20PM GMT
Release Date Price: $11.06 (-3.74%)
Jayson Bedford
Raymond James & Associates, Inc. - Analyst

Okay. Good morning. I think we can get started here. My name is Jayson Bedford. I cover medical devices here at Raymond James. And again, welcome to our annual healthcare conference.

It's really our pleasure to have with us today the team from MiMedx. We have the Company's CEO, Tim Wright; Head of R&D, Dr. Bob Stein; CFO, Pete Carlson; and I think from Investor Relations, we have both Jack Howarth and Hilary Dixon.

So with that, this is going to follow a presentation format, and I will hand it over to Tim.

Tim Wright
MiMedx Group, Inc. - CEO

Thank you very much, Jayson. It's always a -- happy to be part of the Raymond James conference. The theme of this meeting is on innovation, and I think that's what part of MiMedx is all about -- innovation in this area, really better understanding placental science and pioneering our understanding of this science into meaningful medicines.

If we could start with the first slide. (technical difficulty) Okay, let me just kick off

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot